Skip to content

Focus Areas

Focus areas

The world’s most pressing health challenges share a common barrier: access to timely, reliable diagnostics. Whether it’s rapid detection of respiratory infections or infectious diseases or making routine blood collection more convenient and comfortable, diagnostic gaps can lead to knock-on effects for individuals and the wider community.

Sapphiros is purpose-built to close these gaps – directing our integrated technology platform toward the health issues where accessibility, affordability and accuracy can deliver the greatest impact.

Respiratory disease Copied!

The respiratory season is unpredictable — viruses can surge suddenly, affecting communities and straining healthcare systems. Being ready to respond quickly is essential. However, access to quality testing remains inconsistent – particularly in the home and within communities with limited healthcare facilities.

From seasonal influenza to emerging pandemic threats, respiratory infections demand rapid, accurate diagnostics. Early, accurate and accessible testing helps break the cycle of infection before it spreads.

Sapphiros’ molecular and digital lateral flow platforms are designed to detect multiple viruses with a single test and provide easy-to-understand results to people, wherever they are – whether that’s a family managing seasonal illness at home, a clinic serving rural communities, or a healthcare system preparing for the next public health emergency.

Initial Targets

  • Covid-19

  • Influenza A

  • Influenza B

  • RSV

Infectious disease Copied!

Infectious disease disproportionately impacts low- and middle-income countries. Diseases such as malaria and HIV claim millions of lives annually, often due to delayed diagnosis and treatment. Better access to medical facilities and improved logistics and infrastructure can dramatically alter outcomes - reducing the number of deaths and improving the quality of life for others.

Sapphiros is addressing this crisis at scale. Our molecular and lateral flow platforms are purpose-built for the realities of global health – combining extreme manufacturing capacity, ultra-low costs and reliable performance to reach the populations who need testing most.

By producing billions of tests annually and eliminating unnecessary complexity, we’re making it possible to diagnose and treat infectious diseases everywhere – from big cities to remote villages – at a price the world can afford.

Initial targets

  • Malaria

  • HIV

  • STIs

Blood Collection and Detection Copied!

Blood testing remains the foundation of modern healthcare. It is essential for diagnosing disease, monitoring chronic conditions and guiding treatment decisions. However, collecting those samples can be inconvenient and time-consuming, often requiring travel and scheduled appointments. For those managing chronic conditions, repeated clinic visits can become burdensome and costly.

We believe there is a better way. We are reimagining blood collection to remove these barriers entirely. Our at-home collection systems make it possible for anyone to collect high-quality samples from the comfort and convenience of their own home.

By focusing on affordability, ease of use and patient comfort, we’re unlocking access to routine monitoring and diagnostic testing for people who live in remote and underserved communities - ensuring that blood collection will no longer be an obstacle to the care people need.

Initial Targets

  • Blood collection: Return to lab

  • Laboratory HbA1c end-to-end

  • Infectious disease on SatioDx

The products described are in development, are not available for sale, and are not approved, cleared or authorised.